Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Make-or-Break Moments for Celsion in 2013
Motley Fool
Thursday, January 17, 2013 - 8:39am
tags:
Celsion, ThermoDox
What to Watch With Astex in 2013
Motley Fool
Thursday, January 17, 2013 - 8:37am
tags:
Astex, Dacogen
Amgen says it will spend $200M to build antibody drug manufacturing facility in Singapore
Yahoo/AP
Thursday, January 17, 2013 - 8:33am
tags:
Amgen, drug manufacturing, Singapore
Life Sciences: Upcoming Events for Week of January 13
Motley Fool
Wednesday, January 16, 2013 - 12:12pm
tags:
Achillion, NuPathe, Anacor
AstraZeneca Asks U.K. to Encourage Use of Blood-Thinner Brilique
Bloomberg
Wednesday, January 16, 2013 - 11:52am
tags:
AstraZeneca, UK, bloothinners, Brilique
3 Drug Launches You Need to Know in 2013
Motley Fool
Wednesday, January 16, 2013 - 11:18am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome, Iclusig, Ariad, chronic myeloid leukemia, Pfizer, Eliquis, Bristol-Myers Squibb
Hyperion Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti
Yahoo
Wednesday, January 16, 2013 - 11:15am
tags:
Hyperion, FDA, Ravicti, urea cycle disorders
Epigenomics AG Vs. Exact Sciences: Who Wins The CRC Early Detection Fight?
Seeking Alpha
Wednesday, January 16, 2013 - 11:10am
tags:
Epigenomics AG, EXACT Sciences, colorectal cancer
Understanding The Market Opportunity For Pozen's Safer Aspirin
Seeking Alpha
Wednesday, January 16, 2013 - 11:08am
tags:
Pozen, AstraZeneca, Vimovo
Johnson and Johnson's Earnings Should Confirm What a Great Company it Is
Motley Fool
Wednesday, January 16, 2013 - 9:06am
tags:
JNJ, earnings
BI's cancer drug afatinib gets US fast-track review
Pharma Times, UK
Wednesday, January 16, 2013 - 8:38am
tags:
Afatinib, Boehringer Ingelheim, fast track, non-small cell lung cancer
A.P. Pharma Anticipates FDA Decision On APF530
Seeking Alpha
Wednesday, January 16, 2013 - 8:36am
tags:
AP Pharma, FDA, APF530, chemotherapy-induced nausea and vomiting
Bristol-Myers Tries To Settle Hep C Patient Claims
Pharmalot
Wednesday, January 16, 2013 - 8:16am
tags:
hepatitis C, Bristol-Myers Squibb
The Future Of Zalicus In 2013
Seeking Alpha
Wednesday, January 16, 2013 - 8:01am
tags:
Zalicus, Novartis, Questcor, CelSci, Celsion, Antares
Is Celgene All Good as a Long-Term Investment?
Motley Fool
Wednesday, January 16, 2013 - 7:58am
tags:
Celgene
European regulators approve Eli Lilly's Amyvid, which helps with Alzheimer's diagnosis
Yahoo/AP
Wednesday, January 16, 2013 - 7:57am
tags:
Europe, Amyvid, Eli Lilly, Alzheimer's disease
Johnson & Johnson In 2013: New Revenue Sources And Old OTC Troubles Winding Down
Seeking Alpha
Wednesday, January 16, 2013 - 7:56am
tags:
JNJ, recalls
SPR Therapeutics raises $5M Series A round
Mass Device
Tuesday, January 15, 2013 - 11:15pm
tags:
SPR Therapeutics, funding
Patient Safety: Bill Clinton urges healthcare stakeholders not to leave patients "sicker and broke"
Mass Device
Tuesday, January 15, 2013 - 11:15pm
tags:
patient, safety, Healthcare, stock
Monteris Medical closes $7.8M round for brain tumor laser
Mass Device
Tuesday, January 15, 2013 - 11:14pm
tags:
Monteris Medical, brain, tumor, laser, funding

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.